These lab-produced alternatives weren't designed with recreational use in mind. Within the nineties, John W. Huffman and a staff of fellow chemists at Clemson College designed several of the initial formulas for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of can